Long non-coding RNA HAGLROS regulates lipid metabolism reprogramming in intrahepatic cholangiocarcinoma via the mTOR signaling pathway
Related Experiment Video
Updated: Dec 20, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Jun Ma1, Jinfeng Feng1, Xiang Zhou1
1Department of General Surgery, Minhang Hospital, Fudan University, Shanghai 201100, PR China.
Insights
Long non-coding RNA HAGLROS promotes intrahepatic cholangiocarcinoma (ICC) by altering lipid metabolism. Inhibiting HAGLROS inactivates the mTOR axis, enhances autophagy, and improves ICC prognosis, suggesting new therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Long non-coding RNAs (lncRNAs) play a role in intrahepatic cholangiocarcinoma (ICC) development.
- The specific mechanism of HAGLROS, a lncRNA involved in various cancers, in ICC progression is not yet understood.
Purpose of the Study:
- To investigate the role and mechanism of HAGLROS in ICC.
- To analyze the association between HAGLROS expression and ICC prognosis.
- To explore HAGLROS's impact on lipid metabolism and the mTOR/autophagy pathways in ICC.
Main Methods:
- HAGLROS expression was analyzed in ICC tissues and cell lines.
- Cellular processes, lipid accumulation, and protein levels (mTOR axis, autophagy markers) were measured after HAGLROS manipulation (knockdown/overexpression).
- In vivo studies in nude mice assessed serum lipid levels and tumor markers.
Main Results:
- HAGLROS is highly expressed in ICC and correlates negatively with patient prognosis.
- Knocking down HAGLROS reduced lipid accumulation, inhibited ICC cell viability, invasion, and migration, inactivated the mTOR axis, and increased autophagy.
- Overexpressing HAGLROS showed opposite effects; in vivo studies confirmed reduced lipid levels and SREBP1 expression.
Conclusions:
- HAGLROS promotes ICC by reprogramming lipid metabolism via the mTOR axis and autophagy.
- Inhibition of HAGLROS shows therapeutic potential for ICC by modulating lipid metabolism and enhancing autophagy.
Abstract:
Alternation of long non-coding RNA (lncRNA) is implicated in intrahepatic cholangiocarcinoma (ICC) development. HAGLROS is a lncRNA with a length of 699 bp, which is involved in the progression of various cancers. But the mechanism of HAGLROS in ICC remains unknown. In this study, the sh-HAGLROS-1 or sh-HAGLROS-2 was transfected into QBC939 cells, and overexpressing HAGLROS vector was transfected into KMCH cells. HAGLROS expression in ICC tissues and cell lines was detected, and its association with ICC prognosis was further analyzed. Lipid accumulation and lipid-related indicators (TG, LDL-C, TC and HDLC) in QBC939 and KMCH cells were measured. ICC cell viability, invasion and migration were measured. Western blot analysis was used to detect levels of the mTOR axis-related proteins and autophagy-related proteins (LC3I, LC3II, Beclin and P62). The levels of serum lipids and SREBP1 positive expression in transplanted tumors of nude mice were detected. HAGLROS was highly expressed in ICC and negatively correlated with prognosis. QBC939 cells with knocking down HAGLROS exhibited reduced lipid-related protein levels, blocked ICC cellular processes, inactivated mTOR axis, and increased autophagy. QBC939 cells with overexpressing HAGLROS showed opposite trends. The lipid-related protein levels in serum of nude mice and SREBP1 positive expression in transplanted tumors were diminished. Taken together, sh-HAGLROS inactivated the mTOR axis and promoted autophagy, thereby improving lipid metabolism reprogramming in ICC. This study may offer novel ICC treatments.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Experimental RNAi
